focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Share News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.00
Bid: 44.00
Ask: 46.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.545%)
Open: 45.00
High: 45.00
Low: 45.00
Prev. Close: 45.00
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Eneraqua shares plunge on annual profit warning

Wed, 11th Oct 2023 10:52

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Power Metal Resources PLC, up 8.8% at 0.68 pence, 12-month range 0.55-1.85p. The metals exploration and development company reports that extensive radon gas sampling at the Tait Hill and Soaring Bay projects in and around the Athabasca Basin in Saskatchewan, Canada, have confirmed multiple significant uranium targets. Chief Executive Sean Wade says this season's uranium fieldwork continues to surpass the firm's expectations in terms of quality and number of significant targets discovered. "Following very low acquisition costs, we believe we are now adding very considerable value to a portfolio with well thought out, methodical and inexpensive exploration, clearly demonstrating the ongoing success of our business model. We now look forward to the next stage, that of crystallising the value created for our shareholders. We are in discussion with various third parties about ways in which we can do that, and I look forward to updating shareholders on those discussions in due course," the CEO adds.

----------

Cambridge Cognition Holdings PLC, up 6.7% at 74.70 pence, 12-month range 65.35-129.74p. The company wins a "significant" GBP1 million contract for a "sizeable" later stage clinical trial, following a competitive tender. The contract combines the company's Cantab touch-screen cognitive assessments with verbal assessments from its recent Winterlight Labs acquisition. Cambridge Cognition will supply its electronic clinical outcome assessments and provide full training for clinicians, together with quality control services, as part of the contract. Revenue from the contract is expected to be recognised over a two-year period, starting in 2023. Notes there is potential for a further contract with the same customer, of "slightly" higher value, in 2024 once the initial results have been analysed. Cambridge Cognition develops and markets digital solutions to assess brain health.

----------

AIM - LOSERS

----------

Eneraqua Technologies PLC, down 58% at 39.00 pence, 12-month range 38.26-389.60p. The energy and water efficiency solution provider swings to an interim loss amid rising costs and warns of a "material reduction" in profitability in the full-year. Pretax loss in the six months ended July 31 totals GBP441,000, swinging from a profit of GBP3.0 million the year prior. Loss comes as the company records a 20% rise in its cost of sales to GBP17.2 million, and a 31% rise in administrative expenses to GBP9.0 million. The rising costs offsets growth in revenue which rises 7.4% to GBP26.0 million from GBP24.2 million. Chief Executive Mitesh Dhanak adds: "Post-period end the group has faced dual headwinds. The continued and increased budgetary pressures on local government are leading to discussions on slowing down project delivery and deferring works into [financial 2025]. This compounds the impact of the recent unexpected [UK] government policy change in relation to net nutrient neutrality. As a result, the board now expects some projects to be delivered more slowly with revenues moving into next year and reduced operational leverage affecting margins. As a result we expect to see a material reduction in revenues and outturn in profitability during [financial 2024]."

----------

Jubilee Metals Group PLC, down 11% at 6.26 pence, 12-month range 6.01-13.92p. The metal processing company reports that its annual profit more than halved as surging overhead costs put margins under pressure. Posts a pretax profit of GBP12.3 million in the financial year ended June 30, down 54% from GBP26.5 million a year earlier. Profit margins shrink to 22% from 32%, as costs balloon. Cost of sales grow by 17% to GBP110.5 million from GBP94.6 million. Finance costs multiply to GBP5.2 million from GBP1.4 million. Jubilee reports revenue of GBP141.9 million, up slightly 1.4% from GBP140.0 million, with growth in dollar-denominated chrome revenue predominately offsetting a decrease in platinum group metal revenue. Notes that PGM price is now trading at USD1,359 an ounce, which is 46% below the 2022 financial average and 21% below average in the 2023 financial year.

----------

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
2 Feb 2022 12:40

Cambridge Cognition awarded contracts worth £2.1m

(Sharecast News) - Brain health technology company Cambridge Cognition has been awarded contracts worth £2.1m, it announced on Wednesday, to provide cognitive assessments, electronic diaries, and third-party hardware for two clinical trials in neurodegenerative disease.

Read more
2 Feb 2022 10:45

Cambridge Cognition jumps on GBP2.1 million clinical trial contract

Cambridge Cognition jumps on GBP2.1 million clinical trial contract

Read more
2 Feb 2022 10:32

AIM WINNERS & LOSERS: AFC gets Extreme E boost; Chamberlin raises cash

AIM WINNERS & LOSERS: AFC gets Extreme E boost; Chamberlin raises cash

Read more
27 Jan 2022 17:49

TRADING UPDATES: Petropavlovsk expects lower output; Keywords robust

TRADING UPDATES: Petropavlovsk expects lower output; Keywords robust

Read more
10 Jan 2022 12:44

Cambridge Cognition wins contracts for two clinical trials

(Sharecast News) - Brain health technology company Cambridge Cognition has been awarded contracts for two clinical trials by an unnamed "top 20" pharmaceutical company, it announced on Monday, to assess the pro-cognitive effects of a new drug in schizophrenia.

Read more
10 Jan 2022 12:19

Cambridge Cognition wins assessment contracts for schizophrenia drug

Cambridge Cognition wins assessment contracts for schizophrenia drug

Read more
16 Dec 2021 21:55

IN BRIEF: Cambridge Cognition wins second GBP500,000 contract

IN BRIEF: Cambridge Cognition wins second GBP500,000 contract

Read more
10 Dec 2021 15:03

TRADING UPDATES: Omega disputes repayment; BWA applies for licenses

TRADING UPDATES: Omega disputes repayment; BWA applies for licenses

Read more
2 Nov 2021 15:01

EXECUTIVE CHANGES: CFOs drop like flies; ex-IG CEO to chair Scotgold

EXECUTIVE CHANGES: CFOs drop like flies; ex-IG CEO to chair Scotgold

Read more
26 Oct 2021 17:39

TRADING UPDATES: East Star makes buy; Kromek wins USD17 million deal

TRADING UPDATES: East Star makes buy; Kromek wins USD17 million deal

Read more
26 Oct 2021 09:11

Cambridge Cognition secures contract for 'sizeable' schizophrenia trial

(Sharecast News) - Digital brain health technology company Cambridge Cognition has secured a contract for a further sizeable schizophrenia trial with an existing customer, it announced on Tuesday.

Read more
21 Sep 2021 11:54

TRADING UPDATES: Cambridge Cognition in profit; PensionBee loss widens

TRADING UPDATES: Cambridge Cognition in profit; PensionBee loss widens

Read more
14 Sep 2021 16:11

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
3 Aug 2021 12:03

TRADING UPDATES: UK housing market boosts Belvoir; IOG spuds Blythe

TRADING UPDATES: UK housing market boosts Belvoir; IOG spuds Blythe

Read more
3 Aug 2021 09:31

Cambridge Cognition turns in 'strong financial performance' in H1

(Sharecast News) - Software firm Cambridge Cognition said on Tuesday that it had put on a "strong financial performance" in the six months ended 30 June, with both revenue and sales growth during the period.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.